Retroviral, short for aplastic anemia, the survival of patients with retroviral is related to the type of retroviral and the effectiveness of treatment. Patients with non-severe retroviral who are well-treated generally have no impact on survival, while patients with severe retroviral who are poorly treated have a shorter survival period, which may be no more than one year. Retrovascularization is a bone marrow hematopoietic failure disorder that manifests itself as low bone marrow hematopoiesis and decreased numbers of whole blood cells, and patients may experience anemia, bleeding, and infections. Cataracts are usually categorized into non-severe and severe forms. 1. Non-severe cataracts progress more slowly and are less severe than severe cataracts. Generally speaking, non-severe forms of cataract have a better outcome after active and regular treatment, and may have no effect on survival or may survive for a long time. 2. Some patients with remodeled cataract who have poorly controlled disease may progress to severe remodeled cataract over time, in which case their survival may be shortened. Patients with severe forms of remyelination may survive for more than 10 years if they do well on treatment. If treatment is not effective, most patients may die within a short period of time. Specific therapeutic drugs include erythropoietin, testosterone undecanoate, and cyclosporine. Therefore, when a patient is diagnosed with retroviruses, he or she should actively receive regular treatment under the guidance of a physician in order to obtain a better therapeutic effect.